SkinMedica(R) Announces FDA Approval Of Desonate(TM) (Desonide) Gel 0.05% With Patented Hydrogel Technology For Treatment Of Atopic Dermatitis

... SkinMedica, Inc., a specialty pharmaceutical company focused on developing, acquiring and commercializing products that treat dermatologic conditions and diseases and improve the appearance of skin, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for Desonate (desonide gel) 0. [click link for full article] ...